p53 apoptotic response to DNA damage dependent on BCL2 but not bax in head and neck squamous cell carcinoma lines

Head and Neck

Volumn 28, Issue 1, 2006, Pages 15-23

  Crowe, David L ^a   Sinha, Uttam K ^a  

^a UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

Author keywords

bcl2; Cell cycle; Cyclin dependent kinase inhibitor; Double strand break repair; Tumor suppressor

Indexed keywords

CYCLIN DEPENDENT KINASE INHIBITOR; DNA; PROTEIN BAX; PROTEIN BCL 2; PROTEIN P53;

APOPTOSIS; ARTICLE; CANCER CELL CULTURE; CANCER GROWTH; CARCINOGENESIS; CELL CYCLE; CELL CYCLE G1 PHASE; CELL CYCLE G2 PHASE; CONTROLLED STUDY; DNA DAMAGE; DNA REPAIR; GENETIC TRANSCRIPTION; HEAD AND NECK CARCINOMA; HUMAN; HUMAN CELL; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN PROTEIN INTERACTION;

APOPTOSIS; BCL-2-ASSOCIATED X PROTEIN; BCL-ASSOCIATED DEATH PROTEIN; BLOTTING, WESTERN; CARCINOMA, SQUAMOUS CELL; CELL CYCLE; CELL LINE, TUMOR; CHROMOSOME DELETION; CYCLIN-DEPENDENT KINASE INHIBITOR PROTEINS; DNA DAMAGE; GENE EXPRESSION REGULATION, NEOPLASTIC; GENES, P53; HEAD AND NECK NEOPLASMS; HUMANS; MUTATION; PROTEIN-TYROSINE-PHOSPHATASE; PROTO-ONCOGENE PROTEINS C-BCL-2;

EID: 30744454806     PISSN: 10433074     EISSN: 10970347     Source Type: Journal    
DOI: 10.1002/hed.20319     Document Type: Article

References (25)

1. Greenblatt MS, Bennett WP, Hollstein M, Harris CC. Mutations in the p53 tumor suppressor gene, clues to cancer etiology and molecular pathogenesis. Cancer Res 1994;54:4855-4878.
2. Ko LJ, Prives C. p53: puzzle and paradigm. Genes Dev 1996;10:1054-1072.
3. Donehower LA, Harvey M, Slagle BL, et al. Mice deficient for p53 are developmentally normal but susceptible to spontaneous tumors. Nature 1992;356:215-221.
4. Kashiwazaki H, Tonoki H, Tada M, et al. High frequency of p53 mutations in human oral epithelial dysplasia in primary squamous cell carcinoma detected by yeast functional assay. Oncogene 1997;15:2667-2674.
5. el-Naggar AK, Lai S, Luna MA, et al. Sequential p53 mutation analysis of pre-invasive and invasive head and neck squamous carcinoma. Int J Cancer 1995;64:196-201.
6. Prives C. How loops, β sheets, and α helices help us to understand p53. Cell 1994;78:543-546.
7. Levine AJ. p53, the cellular gatekeeper for growth and division. Cell 1997;88:323-331.
8. Vousden KH. p53: death star. Cell 2000;103:691-694.
9. Prives C. Signaling to p53: breaking the mdm2-p53 circuit. Cell 1998;95:5-8.
10. Agarwal ML, Taylor WR, Chernov MV, Chernova OB, Stark GR. The p53 network. J Biol Chem 1998;273:1-4.
11. Bunz F, Dutriaux A, Lengauer C, et al. Requirement for p53 and p21 to sustain G2 arrest after DNA damage. Science 1998;282:1497-1501.
12. Rowan S, Ludwig RL, Haupt Y, et al. Specific loss of apoptotic but not cell cycle arrest function in a human tumor derived p53 mutant. EMBO J 1996;15:827-838.
13. Ryan KM, Vousden KH. Characterization of structural p53 mutants which show selective defects in apoptosis but not cell cycle arrest. Mol Cell Biol 1998;18:3692-3698.
14. Liu TJ, Zhang WW, Taylor DL, Roth JA, Goepfert H, Clayman GL. Growth suppression of human head and neck cancer cells by the introduction of a wild type p53 gene via a recombinant adenovirus. Cancer Res 1994;54:3662-3667.
15. Clayman GL, el-Naggar AK, Roth JA, et al. In vivo molecular therapy with p53 adenovirus for microscopic residual head and neck squamous carcinoma. Cancer Res 1995;55:1-6.
16. Min BM, Baek JH, Shin KH, Gujuluva CN, Cherrick HM, Park NH. Inactivation of the p53 gene by either mutation or HPV infection is extremely frequent in human oral squamous cell carcinoma cell lines. Eur J Cancer B Oral Oncol 1994;30B:338-345.
17. Crowe DL, Yoon E. A common pathway for chemotherapy induced apoptosis in human squamous cell carcinoma lines distinct from that of receptor mediated cell death. Anticancer Res 2003;23:2321-2328.
18. Zong WX, Lindsten T, Ross AJ, MacGregor GR, Thompson CB. BH3-only proteins that bind pro-survival Bcl-2 family members fail to induce apoptosis in the absence of Bax and Bak. Genes Dev 2001;15:1481-1486.
19. Wei MC, Zong WX, Cheng EH, et al. Proapoptotic bax and bak: a requisite gateway to mitochondrial dysfunction and death. Science 2001;292:727-730.
20. Tsang DK, Crowe DL. The mitogen activated protein kinase pathway is required for proliferation but not invasion of human squamous cell carcinoma lines. Int J Oncol 1999;15:519-523.
21. Johnson AC, Murphy BA, Matelis CM, et al. Activator protein 1 mediates induced but not basal epidermal growth factor receptor gene expression. Mol Med 2000;6:17-27.
22. Crowe DL, Brown TN, Kim R, Smith SM, Lee MK. A c-fos/estrogen receptor fusion protein promotes cell cycle progression and proliferation of human cancer cells. Mol Cell Biol Res Comm 2000;3:243-248.
23. Chen X, Ko LJ, Jayaraman L, Prives C. p53 levels, functional domains, and DNA damage determine the extent of the apoptotic response of tumor cells. Genes Dev 1996;10:2438-2451.
24. Polyak K, Waldman T, He TC, Kinzler KW, Vogelstein B. Genetic determinants of p53 induced apoptosis and growth arrest. Genes Dev 1996;10:1945-1952.
25. Crowe DL, Boardman ML, Fong KS. Anti-Fas antibody differentially induces apoptosis in Fas ligand resistant carcinoma lines via a caspase 3 dependent pathway but independent of bcl2 expression. Anticancer Res 1998;18:3163-3170.